169 related articles for article (PubMed ID: 35626184)
21. Factors influencing the decision to share cancer genetic results among family members: An in-depth interview study of women in an Asian setting.
Li ST; Sun S; Lie D; Met-Domestici M; Courtney E; Menon S; Lim GH; Ngeow J
Psychooncology; 2018 Mar; 27(3):998-1004. PubMed ID: 29314485
[TBL] [Abstract][Full Text] [Related]
22. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
23. Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study.
Glenn BA; Chawla N; Bastani R
Ethn Dis; 2012; 22(3):267-73. PubMed ID: 22870568
[TBL] [Abstract][Full Text] [Related]
24. Genetic testing and personalized ovarian cancer screening: a survey of public attitudes.
Meisel SF; Rahman B; Side L; Fraser L; Gessler S; Lanceley A; Wardle J;
BMC Womens Health; 2016 Jul; 16():46. PubMed ID: 27460568
[TBL] [Abstract][Full Text] [Related]
25. Using the Health Belief Model to explore why women decide for or against the removal of their ovaries to reduce their risk of developing cancer.
Herrmann A; Hall A; Proietto A
BMC Womens Health; 2018 Nov; 18(1):184. PubMed ID: 30428865
[TBL] [Abstract][Full Text] [Related]
26. "So what happens next?" exploring the psychological and emotional impact of anti-Mullerian hormone testing.
O'Brien Y; Kelleher C; Wingfield M
J Psychosom Obstet Gynaecol; 2020 Mar; 41(1):30-37. PubMed ID: 30489173
[No Abstract] [Full Text] [Related]
27. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
Steele RJC; Digby J; Chambers JA; O'Carroll RE
BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
[TBL] [Abstract][Full Text] [Related]
28. Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial.
Archer S; Fennell N; Colvin E; Laquindanum R; Mills M; Dennis R; Stutzin Donoso F; Gold R; Fan A; Downes K; Ford J; Antoniou AC; Kurian AW; Evans DG; Tischkowitz M
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681696
[TBL] [Abstract][Full Text] [Related]
29. A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.
Sun L; Brentnall A; Patel S; Buist DSM; Bowles EJA; Evans DGR; Eccles D; Hopper J; Li S; Southey M; Duffy S; Cuzick J; Dos Santos Silva I; Miners A; Sadique Z; Yang L; Legood R; Manchanda R
JAMA Oncol; 2019 Dec; 5(12):1718-1730. PubMed ID: 31580391
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
31. Improving Sexual and Gender Minority Cancer Care: Patient and Caregiver Perspectives From a Multi-Methods Pilot Study.
Kano M; Jaffe SA; Rieder S; Kosich M; Guest DD; Burgess E; Hurwitz A; Pankratz VS; Rutledge TL; Dayao Z; Myaskovsky L
Front Oncol; 2022; 12():833195. PubMed ID: 35600396
[TBL] [Abstract][Full Text] [Related]
32. Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.
Eccles DM; Balmaña J; Clune J; Ehlken B; Gohlke A; Hirst C; Potter D; Schroeder C; Tyczynski JE; Gomez Garcia EB
Adv Ther; 2016 Feb; 33(2):129-50. PubMed ID: 26809252
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
Manchanda R; Patel S; Gordeev VS; Antoniou AC; Smith S; Lee A; Hopper JL; MacInnis RJ; Turnbull C; Ramus SJ; Gayther SA; Pharoah PDP; Menon U; Jacobs I; Legood R
J Natl Cancer Inst; 2018 Jul; 110(7):714-725. PubMed ID: 29361001
[TBL] [Abstract][Full Text] [Related]
34. ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.
Roberts MC; Bryson A; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes K; Wheeler SB
Int J Technol Assess Health Care; 2016 Jan; 32(5):355-361. PubMed ID: 27958190
[TBL] [Abstract][Full Text] [Related]
35. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
[TBL] [Abstract][Full Text] [Related]
36. A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.
Lehmann LS; Weeks JC; Klar N; Garber JE
Genet Med; 2002; 4(5):346-52. PubMed ID: 12394347
[TBL] [Abstract][Full Text] [Related]
37. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of genetic testing for cancer risk assessment programme in Nigeria.
Adejumo PO; Aniagwu TIG; Awolude OA; Oni AO; Ajayi OO; Fagbenle O; Ogungbade D; Kochheiser M; Ogundiran T; Olopade OI
Ecancermedicalscience; 2021; 15():1283. PubMed ID: 34824606
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
40. Pressure garment to prevent abnormal scarring after burn injury in adults and children: the PEGASUS feasibility RCT and mixed-methods study.
Moiemen N; Mathers J; Jones L; Bishop J; Kinghorn P; Monahan M; Calvert M; Slinn G; Gardiner F; Bamford A; Wright S; Litchfield I; Andrews N; Turner K; Grant M; Deeks J
Health Technol Assess; 2018 Jun; 22(36):1-162. PubMed ID: 29947328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
